Freijer JI - Search Results

1

Dioxins, dioxin-like PCBs and non-dioxin-like PCBs in foodstuffs: occurrence and dietary intake in The Netherlands.

Baars AJ, Bakker MI, Baumann RA, Boon PE, Freijer JI, Hoogenboom LA, Hoogerbrugge R, van Klaveren JD, Liem AK, Traag WA, de Vries J. Baars AJ, et al. Among authors: freijer ji. Toxicol Lett. 2004 Jun 15;151(1):51-61. doi: 10.1016/j.toxlet.2004.01.028. Toxicol Lett. 2004. PMID: 15177640

2

Risk assessment of deoxynivalenol in food: concentration limits, exposure and effects.

Pieters MN, Freijer J, Baars BJ, Fiolet DC, van Klaveren J, Slob W. Pieters MN, et al. Adv Exp Med Biol. 2002;504:235-48. doi: 10.1007/978-1-4615-0629-4_25. Adv Exp Med Biol. 2002. PMID: 11924598 Review.

3

Modeling relationships between indoor and outdoor air quality.

Freijer JI, Bloemen HJ. Freijer JI, et al. J Air Waste Manag Assoc. 2000 Feb;50(2):292-300. doi: 10.1080/10473289.2000.10464007. J Air Waste Manag Assoc. 2000. PMID: 10680359

4

Risk assessment in extrapolation of pharmacokinetics from preclinical data to humans.

Teitelbaum Z, Lave T, Freijer J, Cohen AF. Teitelbaum Z, et al. Clin Pharmacokinet. 2010 Sep;49(9):619-32. doi: 10.2165/11533760-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20690784

5

Application of the convection-dispersion equation to modelling oral drug absorption.

Freijer JI, Post TM, Ploeger BA, DeJongh J, Danhof M. Freijer JI, et al. Bull Math Biol. 2007 Jan;69(1):181-95. doi: 10.1007/s11538-006-9122-8. Epub 2006 Oct 6. Bull Math Biol. 2007. PMID: 17024551 Free PMC article.

6

Population pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short- and long-term pharmacokinetics.

Heuberger JA, Guan Z, Oyetayo OO, Klumpers L, Morrison PD, Beumer TL, van Gerven JM, Cohen AF, Freijer J. Heuberger JA, et al. Clin Pharmacokinet. 2015 Feb;54(2):209-19. doi: 10.1007/s40262-014-0195-5. Clin Pharmacokinet. 2015. PMID: 25316574

7

A semiphysiological population model for prediction of the pharmacokinetics of drugs under liver and renal disease conditions.

Strougo A, Yassen A, Krauwinkel W, Danhof M, Freijer J. Strougo A, et al. Drug Metab Dispos. 2011 Jul;39(7):1278-87. doi: 10.1124/dmd.110.037838. Epub 2011 Apr 12. Drug Metab Dispos. 2011. PMID: 21487054 Clinical Trial.

8

First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug development.

Strougo A, Eissing T, Yassen A, Willmann S, Danhof M, Freijer J. Strougo A, et al. J Pharmacokinet Pharmacodyn. 2012 Apr;39(2):195-203. doi: 10.1007/s10928-012-9241-9. Epub 2012 Feb 5. J Pharmacokinet Pharmacodyn. 2012. PMID: 22311388 Free PMC article.

9

Disease system analysis: basic disease progression models in degenerative disease.

Post TM, Freijer JI, DeJongh J, Danhof M. Post TM, et al. Among authors: freijer ji. Pharm Res. 2005 Jul;22(7):1038-49. doi: 10.1007/s11095-005-5641-5. Epub 2005 Jul 22. Pharm Res. 2005. PMID: 16028004

10

Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat.

Geldof M, Freijer J, van Beijsterveldt L, Danhof M. Geldof M, et al. Pharm Res. 2008 Apr;25(4):792-804. doi: 10.1007/s11095-007-9390-5. Epub 2007 Aug 21. Pharm Res. 2008. PMID: 17710515 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters